In a carcinogen-induced bladder cancer model, inhibition of EZH2 resulted in significantly reduced tumor progression only when the adaptive immune system was intact–in mice lacking T-cells, EZH2 inhibitors had little effect. The gene discussed is EZH2; the disease is urinary bladder cancer.